Market News / Story
bioAffinity Technologies receives Japanese patent allowance for CyPath Lung AI-based method
·
bioAffinity Technologies announced a Japan Patent Office Notice of Allowance for its CyPath Lung AI-powered method to predict early-stage lung cancer. Key Highlights: Japan Patent Office issued Notice of Allowance for method predicting lung cancer using CyPath Lung and AI. Patent will be first in Japan for CyPath Lung driven by an AI-built algorithm; issuance follows payment of fee. Japanese patent adds to portfolio of 22 awarded U.S. and foreign patents and 36 pending…